PRKAG2 and cardiomyopathy: The quantum of literature on PRKAG2 cardiomyopathy and its outcomes have been limited and hence, this 7.0 ± 1.5 year follow up data aims to throw light on the distinctive clinical features, natural history and outcomes of this disease.